Citation

Lin J, Lu W, Caravella JA, Campbell AM, Diebold RB, Ericsson A, Fritzen E, Gustafson GR, Lancia DR, Shelekhin T, Wang Z, Castro J, Clarke A, Gotur D, Josephine HR, Katz M, Diep H, Kershaw M, Yao L, Kauffman G, Hubbs SE, Luke GP, Toms AV, Wang L, Bair KW, Barr KJ, Dinsmore C, Walker D, Ashwell S.: Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. J Med Chem, Volume 62 (14), 2019

Authors

Ashwell S., Bair KW, Barr KJ, Campbell AM, Caravella JA, Castro J, Clarke A, Diebold RB, Diep H, Dinsmore C, Ericsson A, Fritzen E, Gotur D, Gustafson GR, Hubbs SE, Josephine HR, Katz M, Kauffman G, Kershaw M, Lancia DR, Lin J, Lu W, Luke GP, Shelekhin T, Toms AV, Walker D, Wang L, Wang Z, Yao L

Journal

J Med Chem

Year

2019

DOI

10.1021/acs.jmedchem.9b00362

PubMed

31199148

Machine-readable

REST APIRDF